申请人:Genentech, Inc.
公开号:US20170145034A1
公开(公告)日:2017-05-25
The invention relates to compounds of Formula (0):
wherein Q, A
1
-A
8
, R
4
and R
5
and each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.